Potential role of p53 on metallothionein induction in human epithelial breast cancer cells

被引:0
作者
L Z Fan
M G Cherian
机构
[1] University of Western Ontario,Department of Pathology
来源
British Journal of Cancer | 2002年 / 87卷
关键词
metallothionein; p53; apoptosis; breast cancer;
D O I
暂无
中图分类号
学科分类号
摘要
The expression and induction of metallothionein has been associated with protection against oxidative stress and apoptosis. This study examines the effect of tumour suppressor protein p53 on metallothionein expression following CdCl2 treatment in eight human epithelial breast cancer cell lines differing in p53 and oestrogen-receptor status. Cells were treated with 10 μM CdCl2 for 24 h and metallothionein protein levels were measured by cadmium binding assay. MCF7 cells which are p53-positive (p53+) and oestrogen-receptor-positive showed a large induction in metallothionein synthesis by 10.79±1.36-fold. Other breast cancer cell lines which are p53-negative (p53−) and oestrogen-receptor-negative or weakly oestrogen-receptor-positive showed a small induction ranging from 1.40±0.10 to 3.65±0.30-fold. RT–PCR analysis showed an induction of metallothionein mRNA in MCF7 cells by about 1.61±0.08-fold, while in HCC1806 cells (p53−, oestrogen-receptor-negative) by 1.11±0.13-fold, and in MDA-MB-231 (p53−, oestrogen-receptor-negative) by 1.25±0.06-fold. Metallothionein localisation was determined by immunohistochemical staining. Prior to metal treatment, metallothionein was localised mainly in the cytoplasm of MCF7 and MDA-MB-231 cells. After treatment with 10 μM CdCl2 for 24 h, MCF7 cells showed intense nuclear and cytoplasmic staining for metallothionein, while MDA-MB-231 cells showed staining in the cytoplasm with weak nuclear staining. Apoptosis induced by 10–40 μM CdCl2 at time points between 4 and 48 h was examined with TUNEL assay. In MCF7 cells, apoptosis increased with higher concentrations of CdCl2, it peaked at 6–8 h and appeared again at 48 h for all concentrations of CdCl2 tested. In MDA-MB-231 cells, apoptosis remained at low levels for 10–40 μM CdCl2 at all time points. Studies on cadmium uptake showed similar uptake and accumulation of cadmium at 8 and 24 h in all the cell lines. The data demonstrate that treatment of epithelial breast cancer cells with 10 μM CdCl2 for 24 h caused a greater induction of metallothionein protein and mRNA expression in p53+ and oestrogen-receptor-positive cells as compared to p53− and oestrogen-receptor-negative or weakly oestrogen-receptor-positive cells. This effect may be associated with the occurrence of apoptosis and suggests a role for p53 and oestrogen-receptor on the expression and induction of metallothionein in epithelial cells.
引用
收藏
页码:1019 / 1026
页数:7
相关论文
共 50 条
  • [41] Role of p53, PUMA, and Bax in wogonin-induced apoptosis in human cancer cells
    Lee, Dae-Hee
    Kim, Clifford
    Zhang, Lin
    Lee, Yong J.
    BIOCHEMICAL PHARMACOLOGY, 2008, 75 (10) : 2020 - 2033
  • [42] The p53/miRNA Axis in Breast Cancer
    Hosseini, Reza Shah
    Nouri, Seyed Mohammad
    Bansal, Pooja
    Hijazi, Ahmed
    Kaur, Harpreet
    Kareem, Anaheed Hussein
    Kumar, Abhinav
    Al Zuhairi, Rafil Adnan Hussein
    AL-Shaheri, Nadhim Allawi
    Mahdavi, Parya
    DNA AND CELL BIOLOGY, 2024, 43 (11) : 549 - 558
  • [43] Serum p53 antibody in breast cancer
    Yamamoto, Shinya
    Chishima, Takashi
    Adachi, Shouko
    Harada, Fumi
    Toda, Youko
    Arioka, Hitoshi
    Hasegawa, Naoki
    Kakuta, Yukio
    CANCER BIOMARKERS, 2014, 14 (04) : 203 - 206
  • [44] EXPRESSION OF SURVIVIN AND p53 IN BREAST CANCER
    Dwijendra, Nath
    Pallavi, Agrawal
    Arun, Singh
    Niharika, Rawat
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (07): : 881 - 885
  • [45] p53 in breast cancer: mutation and countermeasures
    Kumar, Sumit
    Walia, Vijay
    Ray, Maria
    Elble, Randolph C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4168 - 4178
  • [46] Immunoreactive p53 and metallothionein expression in duct carcinoma in situ of the breast - No correlation
    DouglasJones, AG
    Navabi, H
    Morgan, JM
    Jasani, B
    VIRCHOWS ARCHIV, 1997, 430 (05) : 373 - 379
  • [47] Novel quinuclidinone derivatives induced apoptosis in human breast cancer via targeting p53
    Malki, Ahmed
    Elbayaa, Rasha Y.
    Ali, Omnia
    Sultan, Ahmed
    Youssef, Amal M.
    BIOORGANIC CHEMISTRY, 2017, 72 : 57 - 63
  • [48] Purging of human breast cancer cells from stem cell products with an adenovirus containing p53
    Hirai, M
    Kelsey, LS
    Vaillancourt, M
    Maneval, DC
    Watanabe, T
    Talmadge, JE
    CANCER GENE THERAPY, 2000, 7 (02) : 197 - 206
  • [49] Purging of human breast cancer cells from stem cell products with an adenovirus containing p53
    Manabu Hirai
    Linda S Kelsey
    Mei Vaillancourt
    Daniel C Maneval
    Tsutomu Watanabe
    James E Talmadge
    Cancer Gene Therapy, 2000, 7 : 197 - 206
  • [50] The unexplained survival of cells in oral cancer: what is the role of p53?
    Whyte, DA
    Broton, CE
    Shillitoe, EJ
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2002, 31 (03) : 125 - 133